Bayer Cropscience growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+3.7%+7.3%—
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+26.7%−27.7%—
+28.9%−31.3%—
+21.3%−23.3%—
+8.6%+14.1%−1.7%
+4.0%+0.0%+5.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,375.00

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue Growth——+7.3+3.7
EBITDA Growth——-27.7+26.7
EBIT Growth——-31.3+28.9
Net Income Growth——-23.3+21.3
Total Assets Growth—-1.7+14.1+8.6
Total Equity Growth—+5.1+0.0+4.0
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.